-+ 0.00%
-+ 0.00%
-+ 0.00%

Senti Biosciences unit issues USD 2 million senior secured convertible notes to NSG BioInnovation Fund

PUBT·09/04/2026 10:05:00
Listen to the news
Senti Biosciences unit issues USD 2 million senior secured convertible notes to NSG BioInnovation Fund
  • Senti Holdings, a Senti Biosciences unit, closed a USD 2 million sale of Senior Secured Convertible Notes to NSG BioInnovation Fund.
  • Financing completed Sept. 3, 2026 under an April 27, 2026 securities purchase agreement amended Sept. 1, 2026.
  • Note form amended to add NSG as a purchaser under the agreement.
  • Separately, Celadon affiliate committed to buy USD 2.5 million of common stock at Nasdaq’s “Minimum Price” around the merger closing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senti Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-060600), on September 04, 2026, and is solely responsible for the information contained therein.